Small Molecules
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
200
NCT06848348
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
Phase: Phase 2
Role: Lead Sponsor
Start: Feb 21, 2025
Completion: Aug 31, 2026
Loading map...